ATE394106T1 - Verwendung von er-beta selektiven antagonisten als kontrazeptiva - Google Patents

Verwendung von er-beta selektiven antagonisten als kontrazeptiva

Info

Publication number
ATE394106T1
ATE394106T1 AT02706750T AT02706750T ATE394106T1 AT E394106 T1 ATE394106 T1 AT E394106T1 AT 02706750 T AT02706750 T AT 02706750T AT 02706750 T AT02706750 T AT 02706750T AT E394106 T1 ATE394106 T1 AT E394106T1
Authority
AT
Austria
Prior art keywords
contraceptives
selective antagonists
beta selective
erss
antagonists
Prior art date
Application number
AT02706750T
Other languages
English (en)
Inventor
Christa Hegele-Hartung
Karl-Heinrich Fritzemeier
Hiroshi Yamanouchi
Olaf Peters
Dirk Kosemund
Gerd Mueller
Ingo Tornus
Gerd Schubert
Sven Ring
Original Assignee
Bayer Schering Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10151365A external-priority patent/DE10151365A1/de
Application filed by Bayer Schering Pharma Ag filed Critical Bayer Schering Pharma Ag
Application granted granted Critical
Publication of ATE394106T1 publication Critical patent/ATE394106T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/16—Masculine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT02706750T 2001-02-27 2002-02-27 Verwendung von er-beta selektiven antagonisten als kontrazeptiva ATE394106T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27140901P 2001-02-27 2001-02-27
DE10151365A DE10151365A1 (de) 2001-10-17 2001-10-17 17-Chlor-D-Homosteroide als selektive Estrogenrezeptorantagonisten
US32973601P 2001-10-18 2001-10-18

Publications (1)

Publication Number Publication Date
ATE394106T1 true ATE394106T1 (de) 2008-05-15

Family

ID=27214634

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02706750T ATE394106T1 (de) 2001-02-27 2002-02-27 Verwendung von er-beta selektiven antagonisten als kontrazeptiva

Country Status (9)

Country Link
EP (1) EP1365768B1 (de)
JP (1) JP2004529107A (de)
AT (1) ATE394106T1 (de)
AU (1) AU2002240936A1 (de)
DE (1) DE60226416D1 (de)
DK (1) DK1365768T3 (de)
ES (1) ES2305210T3 (de)
PT (1) PT1365768E (de)
UY (1) UY27189A1 (de)

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000011739A1 (en) * 1998-05-01 2000-03-02 Eveready Battery Company, Inc. Heat treated fine carbon for alkaline manganese cathodes

Also Published As

Publication number Publication date
ES2305210T3 (es) 2008-11-01
EP1365768A2 (de) 2003-12-03
WO2002068548A1 (en) 2002-09-06
WO2002068548A9 (en) 2003-02-20
JP2004529107A (ja) 2004-09-24
DE60226416D1 (de) 2008-06-19
PT1365768E (pt) 2008-07-29
EP1365768B1 (de) 2008-05-07
WO2002068548A3 (en) 2003-06-05
AU2002240936A1 (en) 2002-09-12
UY27189A1 (es) 2002-09-30
DK1365768T3 (da) 2008-08-18
WO2002068548A8 (en) 2003-12-24

Similar Documents

Publication Publication Date Title
NO20002788D0 (no) Nye forbindelser
DE69617732D1 (de) Transdermales estradiol/progestogen-pflaster und dessen herstellung
BR0113286A (pt) Pirazóis substituìdos
DE69414398D1 (de) Heterocyclische neurokinin-antagonisten
DE60215000D1 (de) DIHYDROPYRROLOi1,2-AöINDOL- UND TETRAHYDROPYRIDOi1,2-AöINDOLDERIVATE ALS PROSTAGLANDIN REZEPTOR ANTAGONISTEN
DE69616480D1 (de) Piperidinderivate als neurokininantagonisten
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
ATE420097T1 (de) Substituierte sapogenine und ihre verwendung
ATE231872T1 (de) Thiazolopyrimidinderivate
ATE218142T1 (de) Nitratester von corticoid verbindungen und die therapeutische verwendungen davon
NO965516L (no) Sterolderivater anvendt til regulering av meiose
DK0806952T3 (da) Progesteronantagonister til fremstillingen af lægemidler til behandling af dysfunktionelle uterine blødninger
DE69906944D1 (de) 20-hete antagonisten und agonisten
BR0017157A (pt) Derivados de 6-hidroxi-indazol para o tratamento de glaucoma
ES2188984T3 (es) Procedimiento de enriquecimiento en r de epimeros de derivados de 16,17-acetales de derivados de 21-aciloxi-pregnano-1,4-dieno-11-beta, 16alfa-triol-3,20-dionas.
ATE318328T1 (de) Diagnostika und therapeutika für osteoporose
ATE375359T1 (de) Aminosterolderivate und ihre verwendungen
AU2001290480A1 (en) Cyclized benzamide neurokinin antagonists for use in therapy
NO20033318L (no) 2H-1-benzopyranderivater, fremgangsmåte ved fremstilling samt farmasöytiskesammensetninger derav
MX9604762A (es) Nuevas sulfonamidas y procedimiento para su preparacion.
DE60226416D1 (de) Verwendung von er-beta selektiven antagonisten als kontrazeptiva
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
IT1289154B1 (it) Derivati di isoflavone loro preparazione e loro impiego terapeutico
TR200100475T2 (tr) N-İkameli azabisikloheptan türevlerinin üretimleri ve kullanımları.
MXPA03008406A (es) Nuevas composiciones de medicamentos sobre la base de agentes anticolinergicos y agentes antagonistas de endotelina.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1365768

Country of ref document: EP

REN Ceased due to non-payment of the annual fee